Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The impact a hospital has on the surrounding neighborhood is a relationship that depends on stability. Even the greatest hospitals can have a less than positive effect on their partnering neighbors.
People who cannot speak and must rely on vocal devices are often stuck with an autonomous one. But now, VocaliD offering personalized voices to those who don’t have one.
Researchers from New York's Icahn School of Medicine at Mount Sinai have developed a tool that can change the level of two types of proteins within a cell. This tool gives researchers a faster and easier way to study cells, particularly stem cells.
Injecting human stem cells into animal embryos will no longer make researchers ineligible for National Institutes of Health Funding, the agency announced August 4.
Chemotherapy's side effects can take a massive toll on the body. In an effort to reduce the killing of healthy cells, researchers from the University of Pennsylvania have developed a computer model that helps design nanocarriers to guide drugs to specific areas within the body.
The Food and Drug Administration has issued a Class 1 recall alert, its most serious recall classification, for Dräger’s VentStar Oxylog 3000 Disposable Pediatric Patient Circuit due to a leaking issue which could kill patients.
The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns.
If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?
